Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05600101 · ClinicalTrials.gov registry record · NA
Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05600101 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 18 participants.
The verdict
NCT05600101, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.
Interventions
- BEHAVIORAL Care.Coach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2023-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05600101
The ClinicalTrials.gov registry entry for NCT05600101 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Care.Coach is the first listed.
NCT05600101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05600101 about?
NCT05600101 is a clinical study titled "Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation". The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.
What is the current status of trial NCT05600101?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-12-06. Estimated completion is 2023-05-16.
What interventions are being tested in trial NCT05600101?
The interventions under investigation include: Care.Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT05600101?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.